Showing results (81-90 of 146) with videos related to
Sort By:
Pageof 15
Journal of Clinical Pharmacology|May 22, 2014
An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysisJo-Anne S Wilson, Kerry B Goralski, Steven D Soroka, et al.The Canadian Journal of Cardiology|March 19, 2005
Population-based evaluation of the management of antithrombotic therapy for atrial fibrillationDavid R Anderson, Martin J Gardner, Wayne Putnam, et al.The New England Journal of Medicine|September 26, 2003
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosisPhilip S Wells, David R Anderson, Marc Rodger, et al.Thrombosis Research|July 9, 2011
Psychological impact of thrombophilia testing in asymptomatic family membersMartha L Louzada, Monica Taljaard, Nicole J Langlois, et al.Journal of Occupational and Environmental Medicine|March 17, 2011
Evaluation of a best-practice worksite wellness program in a small-employer setting using selected well-being indicesRay M Merrill, Steven G Aldana, James E Pope, et al.Journal of Vascular Surgery|April 13, 2015
Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial diseaseEhrin J Armstrong, David R Anderson, Khung-Keong Yeo, et al.Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)David R Anderson, Shridhar Hegde, Emily Reinhard, et al.Journal of Pharmaceutical Sciences|May 2, 2008
Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in ratsPo-Chang Chiang, Sarah A South, J Scott Daniels, et al.The Annals of Thoracic Surgery|October 5, 2015
Hybrid Procedure for Neonates With Hypoplastic Left Heart Syndrome at High-Risk for Norwood: Midterm OutcomesMichael O Murphy, Hannah Bellsham-Revell, Gareth J Morgan, et al.The Journal of Bone and Joint Surgery. American Volume|November 14, 2002
Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplastyDavid R Anderson, S Jo-Anne Wilson, Jennifer Blundell, et al.Pageof 15